Statistics

Total Visits

Views
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults(legacy) 179
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults(legacy) 100

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults 5 1 3 1 6 2 5

File Downloads

Views

Top Country Views

Views
United States 58
Australia 39
China 31
Germany 17
France 10
Netherlands 8
Singapore 5
Vietnam 5
Hong Kong SAR China 2
Sweden 2

Top City Views

Views
Kaleen 22
Beijing 20
Ashburn 18
Fairfield 10
Rotterdam 8
Cambridge 5
Hanoi 5
Chicago 3
Singapore 3
Tettnang Castle 3